BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
Title:
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
Author:
Ma, Yuxiang Huang, Yan Zhao, Yuanyuan Zhao, Shen Xue, Jinhui Yang, Yunpeng Fang, Wenfeng Guo, Ye Han, Yaqian Yang, Kunyu Li, Yongsheng Yang, Jun Fu, Zhenming Chen, Gang Chen, Likun Zhou, Ningning Zhou, Ting Zhang, Yaxiong Zhou, Huaqiang Liu, Qianwen Zhu, Yi Zhu, Hai Xiao, Sa Zhang, Li Zhao, Hongyun